We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AFL icon
301
Aflac
AFL
$63.9B
$39.3M 0.06%
358,174
-67,700
-16% -$7.5M
KEYS icon
302
Keysight
KEYS
$54.5B
$39.1M 0.06%
138,635
+8,500
+7% +$2.13M
WBS icon
303
Webster Financial
WBS
$12.3B
$38.9M 0.06%
+561,000
New +$38.4M
FTNT icon
304
Fortinet
FTNT
$112B
$38.9M 0.06%
476,290
-19,400
-4% -$1.57M
BKR icon
305
Baker Hughes
BKR
$56.8B
$38.8M 0.06%
635,302
+304,400
+92% +$17.6M
YUM icon
306
Yum! Brands
YUM
$41B
$38.7M 0.06%
248,702
+48,500
+24% +$7.68M
IDXX icon
307
Idexx Laboratories
IDXX
$42.9B
$38.4M 0.06%
68,301
+16,254
+31% +$10.4M
LLYVK icon
308
Liberty Live Group Series C
LLYVK
$9.11B
$38M 0.06%
403,607
+134,791
+50% +$12.1M
BDX icon
309
Becton Dickinson
BDX
$43.1B
$37.9M 0.06%
+241,115
New +$44.3M
ETOR
310
eToro Group
ETOR
$2.93B
$37.7M 0.06%
1,256,719
+16,380
+1% +$501K
AXS icon
311
AXIS Capital
AXS
$8.59B
$37.5M 0.06%
370,000
+100,000
+37% +$10.3M
OKE icon
312
Oneok
OKE
$58.7B
$37.4M 0.06%
413,700
+270,600
+189% +$22.3M
RRX icon
313
Regal Rexnord
RRX
$14.2B
$37.4M 0.06%
199,524
+133,198
+201% +$24.8M
THG icon
314
Hanover Insurance
THG
$7.63B
$37.3M 0.06%
215,370
+147,370
+217% +$25.6M
EGP icon
315
EastGroup Properties
EGP
$11.5B
$37M 0.06%
200,000
+116,396
+139% +$21.7M
SUNB
316
Sunbelt Rentals Holdings
SUNB
$31B
$36.8M 0.06%
+565,000
New +$39.7M
HUBS icon
317
HubSpot
HUBS
$10.5B
$36.6M 0.06%
150,000
+25,000
+20% +$7.01M
STLD icon
318
Steel Dynamics
STLD
$35.6B
$36.5M 0.06%
203,000
+54,100
+36% +$9.85M
AES icon
319
AES
AES
$10.6B
$36.4M 0.06%
2,585,312
+1,942,400
+302% +$28.9M
DRUG
320
Bright Minds Biosciences
DRUG
$700M
$36.2M 0.06%
495,743
+100,000
+25% +$8.05M
ROK icon
321
Rockwell Automation
ROK
$51.4B
$36.1M 0.06%
100,700
+21,475
+27% +$8.47M
FITB
322
Fifth Third Bancorp
FITB
$52B
$36.1M 0.06%
+776,297
New +$38.3M
NAMS icon
323
NewAmsterdam Pharma
NAMS
$3.47B
$35.4M 0.05%
1,106,631
-300,000
-21% -$9.77M
MAZE
324
Maze Therapeutics
MAZE
$1.53B
$35.2M 0.05%
+1,178,000
New +$52M
WTW icon
325
Willis Towers Watson
WTW
$27.9B
$34.9M 0.05%
120,188
+53,700
+81% +$16.5M
11 12
13
14 15

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.